Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06046170 · ClinicalTrials.gov registry record · NA
Adaptation and Feasibility of the Community-Based Anxiety Program Tailored for Autism (CAPTA)
A NA study, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT06046170 is a NA study that has completed, run by Baylor College of Medicine. The registered enrollment target is 32 participants.
The verdict
NCT06046170, a NA study, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
Anxiety is very common in autistic youth. Recently, an intervention has been created by the investigators to target these symptoms in autistic youth in a community setting. The purpose of this study is to determine the feasibility of implementing this treatment in community care centers.
Interventions
- OTHER Treatment as Usual
- BEHAVIORAL Cognitive Behavioral Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2024-01-15 |
| Est. Completion | 2026-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06046170
The ClinicalTrials.gov registry entry for NCT06046170 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Treatment as Usual is the first listed.
NCT06046170 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06046170 about?
NCT06046170 is a clinical study titled "Adaptation and Feasibility of the Community-Based Anxiety Program Tailored for Autism (CAPTA)". Anxiety is very common in autistic youth. Recently, an intervention has been created by the investigators to target these symptoms in autistic youth in a community setting. The purpose of this study is to determine the feasibility of implementing this treatment in community care centers.
What is the current status of trial NCT06046170?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2024-01-15. Estimated completion is 2026-02-28.
What interventions are being tested in trial NCT06046170?
The interventions under investigation include: Treatment as Usual (OTHER), Cognitive Behavioral Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT06046170?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.